Cargando…
Colon cancer-specific diagnostic and prognostic biomarkers based on genome-wide abnormal DNA methylation
Abnormal DNA methylation is a major early contributor to colon cancer (COAD) development. We conducted a cohort-based systematic investigation of genome-wide DNA methylation using 299 COAD and 38 normal tissue samples from TCGA. Through conditional screening and machine learning with a training coho...
Autores principales: | Wang, Yilin, Zhang, Ming, Hu, Xiaoyun, Qin, Wenyan, Wu, Huizhe, Wei, Minjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746390/ https://www.ncbi.nlm.nih.gov/pubmed/33202377 http://dx.doi.org/10.18632/aging.103874 |
Ejemplares similares
-
Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer
por: Zhang, Ming, et al.
Publicado: (2020) -
Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in oxaliplatin-based chemotherapy
por: Hu, Xiaoyun, et al.
Publicado: (2018) -
DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma
por: Tang, Yunliang, et al.
Publicado: (2020) -
Multi-omic characterization of genome-wide abnormal DNA methylation reveals diagnostic and prognostic markers for esophageal squamous-cell carcinoma
por: Xi, Yiyi, et al.
Publicado: (2022) -
Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers
por: Exner, Ruth, et al.
Publicado: (2015)